Development of 5N-Bicalutamide, a High-Affinity Reversible Covalent Antiandrogen

Document Details

Document Type
Pub Defense Publication
Publication Date
Nov 02, 2017
Source ID
10.1021/acschembio.7b00702

Entities

People

  • Boxue Tian
  • Charles Truillet
  • Felipe De Jesus Cortez
  • Kristopher M. Kuchenbecker
  • Matthew P. Jacobson
  • Michael J. Evans
  • Pamela M England
  • Paul Webb
  • Phuong Nguyen
  • Robert J. Fletterick

Organizations

  • American Cancer Society
  • California Institute for Quantitative Biosciences
  • California Institute for Regenerative Medicine
  • National Cancer Institute
  • National Institute of General Medical Sciences
  • United States Department of Defense
  • University of California, San Francisco